Colgate-Palmolive Company (CL) closed at $94.11 on October 16, 2026, up 1.6% from the previous close, on volume of 5,311,172 shares (30-day average 5,155,949).
Data as of October 16, 2026.
16-Oct-2026
Goldman's defensive stocks with quality-growth characteristics
Seeking Alpha News (Sun, 18-Oct 11:04 AM ET)
The Week That Was, The Week Ahead: Macro and Markets, October 18
TipRanks (Sun, 18-Oct 4:28 AM ET)
Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39
Seeking Alpha News (Fri, 16-Oct 3:00 PM ET)
Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and more
Seeking Alpha News (Fri, 16-Oct 8:48 AM ET)
Business Wire (Fri, 16-Oct 8:35 AM ET)
Colgate-Palmolive (CL) Receives a Hold from Barclays
TipRanks (Fri, 16-Oct 2:35 AM ET)
UBS Keeps Their Buy Rating on Colgate-Palmolive (CL)
TipRanks (Thu, 15-Oct 6:37 AM ET)
Seeking Alpha News (Tue, 13-Oct 4:59 PM ET)
Tom's of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand
PRNewswire (Wed, 23-Sep 9:05 AM ET)
Colgate-Palmolive Declares Regular Quarterly Dividend
Business Wire (Thu, 17-Sep 4:35 PM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of October 16, 2026, CL stock price climbed to $94.11 with 5,311,172 million shares trading.
CL has a beta of 0.16, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.01 to the broad based SPY ETF.
CL has a market cap of $75.43 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.99 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.
In the last 3 years, CL traded as high as $109.30 and as low as $71.22.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VO.
CL has outperformed the market in the last year with a price return of +24.0% while the SPY ETF gained +16.7%. However, in the short term, CL had mixed performance relative to the market. It has underperformed in the last 3 months, returning +0.6% vs +1.9% return in SPY. But in the last 2 weeks, CL shares have fared better than the market returning +11.7% compared to SPY -0.8%.
CL support price is $91.39 and resistance is $93.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.